According to the Market Statsville Group (MSG), the Global Softgel Capsules Market size is expected to grow from USD 8,921.6 million in 2023 to USD 14,377.4 million by 2033, at a CAGR of 6.6% from 2023 to 2033. 

Softgel capsules encapsulate liquid or semi-liquid substances, making them easy to swallow and precise to dose. A softgel capsule's outer shell is made of gelatin, a protein derived from animal collagen. Compared to traditional hard gelatin capsules, gelatin provides a soft and flexible texture that makes it easier to swallow. This property is especially useful for people with difficulty swallowing pills or tablets. Softgel capsules have increased bioavailability and faster absorption, quickly dissolving in the gastrointestinal tract. They also act as an airtight and light-resistant barrier, extending the shelf life of sensitive compounds.

The increasing awareness for preventive healthcare and growing supplement consumption demand across the world has driven the softgel capsules market. As it ensures accurate dosing and efficient active ingredients, thereby more consumers seek natural and alternative remedies for their health. The rise of pharmaceutical and nutraceutical contract manufacturing organizations (CMOs) is another significant factor driving the softgel capsules market. These CMOs provide pharmaceutical and supplement companies looking to outsource their manufacturing processes with efficient and cost-effective solutions. The versatility of softgel capsules enables CMOs to work with a diverse range of active ingredients, catering to the unique requirements of their clients and fueling the market growth.

Upcoming Trends and Growth Opportunities in the Global Softgel Capsules Market 

Stakeholders in the softgel capsules market, including pharmaceutical companies, nutraceutical manufacturers, and dietary supplement producers, should monitor and adapt to these trends to capitalize on the opportunities for growth and innovation in the industry.

• Nutraceuticals and Dietary Supplements: Rising demand has led to an increased preference for softgel capsules as a dosage form.
• CBD and Cannabis Products: With the rise in CBD and cannabis product approval, there is an increase in desire for softgel pills as a simple and accurate distribution means.
• Pharmaceutical Applications: Oral and targeted drug delivery have benefited from the increased use of softgel capsules in pharmaceuticals.
• Personalized Medicine: Tailoring dosages to suit individual patients' requirements, customized softgel capsules provide a personalized healthcare experience.
• Plant-Based Softgels: An alternative to traditional gelatin-based capsules, rising interest in plant-based and vegan softgels exists.
• Novel Formulations: Research is being conducted on groundbreaking combinations such as softgel capsules containing multiple dynamic elements.
• Functional Foods: Enhancing their nutritional value, softgel capsules are incorporated into functional food products.
• Regulatory Support: Harmonization of frameworks leads to greater clarity regarding softgel capsules' application.
• Global Expansion: Softgel capsule benefits are being recognized by increasing number of consumers, creating market potential.
• Sustainable Packaging: In response to environmental worries, eco-friendly and sustainable packaging materials for softgel capsules have been adopted.

Softgel Capsules Market Segmental Analysis, 2023-2033

Based on type, the market is divided into gelatin /animal based, and non-animal based. The gelatin /animal based segment accounted for the largest market share in 2023. The soft and flexible outer shell of softgel capsules is made primarily of gelatin, a protein derived from animal collagen. Its widespread use can be attributed to its distinct properties, making it an excellent choice for encapsulating various liquid and semi-liquid fill materials. It acts as a stable and protective barrier for sensitive compounds, protecting them from moisture, oxygen, and light.

Based on the regions, the global softgel capsules market has been segmented across Europe, North America, the Middle East & Africa, Asia-Pacific, and South America. North America accounted for the largest market share in 2023. To support their overall well-being, the region's population has been increasingly embracing preventive healthcare and dietary supplements. Softgel capsules appeal to health-conscious consumers by providing a convenient and efficient delivery system for various vitamins, minerals, herbal extracts, and other nutraceutical ingredients. Furthermore, North America's aging population has increased demand for pharmaceutical products in general. Softgel capsules are convenient for elderly people who have difficulty swallowing traditional tablets or pills. Due to their smooth texture and ease of ingestion, they are a popular choice for medication adherence among the elderly. 

Softgel Capsules Market Key Players, 2023

The Major key players in the global softgel capsules market are: 

• Fuji Capsules Co Ltd
• Sirio Pharma
• Captek
• Patheon
• Catalent
• Eurocaps
• Aenova
• Capsugel
• Procaps Laboratories
• Soft Gel Technologies Inc.
• Best Formulations, Inc.
• Robinson Pharma, Inc.
• Lyfe Group (Caps Canada)
• Thermofisher Scientific, Inc (Patheon)
• DCC Plc

Recent Developments

• In September 2022, Everstone Capital acquired Softgel Healthcare (SHPL). This partnership aims to transform SHPL into a scaled, diversified, and globally recognized contract research, development, and manufacturing organization in India with the support of the strategic resources of Everstone.
• In May 2022, Pfizer Inc. acquired Biohaven. The proposed transaction includes acquiring Biohaven’s calcitonin gene-related peptide (CGRP) programs, including Rimegepant, Zavegepant, and a portfolio of five pre-clinical CGRP assets.

Report Scope of the Global Softgel Capsules Market 

This market research study categorizes the softgel capsules market-based on type, application, and manufacturer area at the regional and global levels.

By Type Outlook (Sales, USD Million, 2019-2033)

• Gelatin /Animal Based
• Non-Animal Based 

By Application Outlook (Sales, USD Million, 2019-2033)

• Antacid & Anti-flatulent Preparations
• Anti-anemic Preparations
• Anti-inflammatory Drugs
• Antibiotic & Antibacterial Drugs
• Cough & Cold Preparations
• Health Supplement
• Vitamin & Dietary Supplement
• Pregnancy

By Manufacturers Outlook (Sales, USD Million, 2019-2033)

• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Contract Manufacturing Organizations

By Region Outlook (Sales, USD Million, 2019-2033)

• North America 
  • US
  • Canada
  • Mexico
• Europe 
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA